Bearish
Pfizer's stock drops 2.47% to $23.72 amid CFO departure and reaffirmed 2026 guidance.
Pfizer's stock declined by 2.47% to $23.72 following the announcement of CFO Dave Denton's unexpected departure, effective August 15, 2026. Despite this, the company reaffirmed its 2026 financial guidance, projecting revenues between $59.5 billion and $62.5 billion and adjusted diluted EPS between $2.80 and $3.00.
Key points
- CFO Dave Denton to depart on August 15, 2026.
- Pfizer reaffirms 2026 financial guidance.
- Stock closes at $23.72, down 2.47%.
Sources
AI-generated from public news sources. Not financial advice.
